Status:
COMPLETED
Inflammatory Markers in Saliva of Patients With Burning Mouth Syndrome
Lead Sponsor:
Universidad de Murcia
Conditions:
Burning Mouth Syndrome
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
Burning Mouth Syndrome (BMS) is a chronic pain disorder that presents with inflammation and burning sensation in the oral cavity without visible lesions. Multiple therapies have been investigated with...
Detailed Description
Methods: Randomised, single-blind clinical trial with 89 patients divided into Group 1 Laser + Rivotril (n=20), Group 2 Laser Sham placebo (n=19), Group 3 Laser (n=21) and Group 4 Rivotril (n=18). The...
Eligibility Criteria
Inclusion
- Clinical diagnosis Burning Mouth Syndrome (BMS) burning sensation in the oral mucosa or recurrent dysesthetics daily for more than 2 hours a day for more than 3 months, without clinically evident causal lesions
Exclusion
- Pregnant or lactating patients
- Oncology patients
- Sjögren's syndrome
Key Trial Info
Start Date :
January 10 2022
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 10 2023
Estimated Enrollment :
20 Patients enrolled
Trial Details
Trial ID
NCT06217731
Start Date
January 10 2022
End Date
December 10 2023
Last Update
July 31 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Pia Lopez Jornet
Murcia, Spain, 30004